Patients in high FEZF1‐AS1 expression group have worse lymphatic metastasis (P < .001), deeper invasion (P = .004), distant metastasis (P = .021), advanced TNM Classification of Malignant Tumours (TNM) stage (P < .001) and FIGO Stage (P = .008). This evidence concerns the gene FEZF1 and cancer.